X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3511) 3511
Publication (164) 164
Newsletter (90) 90
Magazine Article (18) 18
Newspaper Article (16) 16
Dissertation (10) 10
Book Review (7) 7
Web Resource (4) 4
Book Chapter (2) 2
Paper (2) 2
Trade Publication Article (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ramipril (2195) 2195
humans (1891) 1891
male (1550) 1550
female (1076) 1076
angiotensin-converting enzyme inhibitors - therapeutic use (1059) 1059
ramipril - therapeutic use (1038) 1038
middle aged (857) 857
animals (760) 760
index medicus (756) 756
hypertension (688) 688
hypertension - drug therapy (677) 677
aged (662) 662
angiotensin-converting enzyme inhibitors - pharmacology (616) 616
ramipril - pharmacology (598) 598
blood pressure - drug effects (591) 591
cardiac & cardiovascular systems (561) 561
rats (555) 555
adult (511) 511
pharmacology & pharmacy (492) 492
antihypertensive agents - therapeutic use (479) 479
peripheral vascular disease (467) 467
treatment outcome (426) 426
ramipril - administration & dosage (355) 355
risk factors (349) 349
drug therapy, combination (342) 342
medicine, general & internal (300) 300
ace inhibitors (296) 296
double-blind method (288) 288
hypertension - physiopathology (278) 278
mortality (275) 275
angiotensin-converting enzyme inhibitors - administration & dosage (270) 270
blood-pressure (253) 253
blood pressure (246) 246
captopril (245) 245
telmisartan (240) 240
angiotensin-converting enzyme inhibitors (232) 232
prevention (232) 232
time factors (229) 229
angiotensin (227) 227
angiotensin-converting enzyme inhibitors - adverse effects (226) 226
urology & nephrology (224) 224
ramipril - adverse effects (216) 216
drug therapy (210) 210
risk (210) 210
research (198) 198
cardiovascular diseases - prevention & control (197) 197
heart-failure (195) 195
randomized controlled trials as topic (192) 192
diabetes (188) 188
disease (186) 186
renin-angiotensin system - drug effects (186) 186
prospective studies (183) 183
cardiovascular events (181) 181
enalapril (181) 181
ramipril - analogs & derivatives (180) 180
follow-up studies (179) 179
dose-response relationship, drug (176) 176
antihypertensive agents - pharmacology (172) 172
benzimidazoles - therapeutic use (171) 171
hypertension - complications (171) 171
bradykinin (168) 168
antihypertensive agents - administration & dosage (164) 164
angiotensin ii type 1 receptor blockers - therapeutic use (163) 163
trial (163) 163
renin-angiotensin system (157) 157
myocardial-infarction (155) 155
losartan (154) 154
benzoates - therapeutic use (147) 147
heart failure (144) 144
rats, sprague-dawley (140) 140
analysis (136) 136
angiotensin-converting enzyme (134) 134
enzymes (133) 133
bradykinin - pharmacology (130) 130
proteinuria (128) 128
cardiovascular diseases (126) 126
care and treatment (125) 125
heart failure - drug therapy (125) 125
nephropathy (125) 125
progression (121) 121
rats, inbred shr (121) 121
clinical trials as topic (120) 120
bridged bicyclo compounds - pharmacology (119) 119
cardiovascular disease (117) 117
health aspects (117) 117
cardiovascular diseases - drug therapy (116) 116
antihypertensive agents - adverse effects (114) 114
therapy (114) 114
rats, wistar (113) 113
dosage and administration (112) 112
aged, 80 and over (111) 111
disease progression (108) 108
stroke (108) 108
valsartan (108) 108
atherosclerosis (107) 107
medicine & public health (107) 107
hemodynamics - drug effects (105) 105
myocardial infarction - drug therapy (105) 105
myocardial infarction (104) 104
outcomes (103) 103
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3223) 3223
German (166) 166
Russian (82) 82
French (56) 56
Spanish (24) 24
Chinese (18) 18
Hungarian (16) 16
Italian (14) 14
Polish (12) 12
Japanese (7) 7
Portuguese (7) 7
Croatian (6) 6
Czech (5) 5
Turkish (3) 3
Ukrainian (3) 3
Dutch (2) 2
Korean (2) 2
Lithuanian (2) 2
Swedish (2) 2
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta Ophthalmologica, ISSN 1755-375X, 09/2012, Volume 90
Purpose to assess the effect of Ramipril 2% eyedrops on visual function in patients with Stargardt’s disease. Methods We conducted a prospective,... 
Ramipril
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 2007, Volume 66, Issue 2, pp. 227 - 243
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, p. A148
Le syndrome des antisynthetases est une connectivite rare caracterisee par l'association d'atteintes cutanees, musculaires, pulmonaires interstitielles,... 
RNA | Ramipril
Journal Article
Medizinische Klinik, ISSN 0723-5003, 01/2010, Volume 105, Issue 1, p. 26
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 10/2015, Volume 765, pp. 307 - 315
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9638, pp. 547 - 553
Summary Background Angiotensin receptor blockers (ARB) and angiotensin converting enzyme (ACE) inhibitors are known to reduce proteinuria. Their combination... 
Internal Medicine | COOPERATE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | RENIN-ANGIOTENSIN SYSTEM | DISEASE | PROTEINURIA | CONVERTING ENZYME-INHIBITORS | COMBINATION | NEPHROPATHY | II RECEPTOR BLOCKERS | PROGRESSION | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Ramipril - administration & dosage | Proteinuria - chemically induced | Cardiovascular Diseases - complications | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Benzimidazoles - therapeutic use | Kidney - drug effects | Double-Blind Method | Diabetes Mellitus - drug therapy | Proteinuria - metabolism | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Benzoates - administration & dosage | Creatinine - blood | Aged | Urine | Drugs | Studies | Kidneys | Disease | Clinical trials | Risk | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2009, Volume 361, Issue 17, pp. 1639 - 1650
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2008, Volume 358, Issue 15, pp. 1547 - 1559
This large trial compared the angiotensin-receptor blocker telmisartan, the angiotensin-converting–enzyme inhibitor ramipril, and combination therapy with both... 
MEDICINE, GENERAL & INTERNAL | DESIGN | LEFT-VENTRICULAR DYSFUNCTION | MYOCARDIAL-INFARCTION | CARDIOVASCULAR EVENTS | DOUBLE-BLIND | SYSTOLIC DYSFUNCTION | RANDOMIZED CLINICAL-TRIALS | CONGESTIVE-HEART-FAILURE | COMBINATION | CONVERTING-ENZYME-INHIBITORS | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Male | Risk | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Benzimidazoles - therapeutic use | Double-Blind Method | Diabetes Mellitus - drug therapy | Kaplan-Meier Estimate | Hospitalization | Creatinine - blood | Angioedema - chemically induced | Aged | Complications and side effects | Ramipril | Drug therapy, Combination | Diabetes | Cardiovascular diseases | Drug therapy | Comparative analysis | Risk factors | Telmisartan | Clinical trials | Vein & artery diseases | Cardiovascular disease | Pharmacology | Clinical outcomes | Index Medicus | Abridged Index Medicus | Blood Pressure | Benzimidazoles | Cardiovascular Diseases | MEDICIN OCH HÄLSOVETENSKAP | Angiotensin II Type 1 Receptor Blockers | epidemiology | Angiotensin-Converting Enzyme Inhibitors | Combination | MEDICAL AND HEALTH SCIENCES | Creatinine | chemically induced | Benzoates | drug therapy | Angioedema | drug effects | Diabetes Mellitus | blood | adverse effects | mortality | therapeutic use | Kaplan-Meiers Estimate
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10085, pp. 2226 - 2237
Summary Background Studies have challenged the appropriateness of accepted blood pressure targets. We hypothesised that different levels of low blood pressure... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | ONGOING TELMISARTAN | METAANALYSIS | RAMIPRIL | RATIONALE | DISEASE | TARGETS | COMBINATION | HYPERTENSIVE PATIENTS | ANTIHYPERTENSIVE TREATMENT | Benzoates - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Randomized Controlled Trials as Topic - methods | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Hospitalization - statistics & numerical data | Hypertension - drug therapy | Male | Multicenter Studies as Topic | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hypotension - mortality | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Benzimidazoles - therapeutic use | Cardiovascular Diseases - physiopathology | Antihypertensive Agents - therapeutic use | Hypotension - chemically induced | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Telmisartan | Hypotension - complications | Aged | Blood pressure | Hospitals | Research institutes | Germany | Myocardial infarction | Heart | Intervention | Syngeneic grafts | Funding | Medical services | Clinical trials | Cardiovascular disease | Blood | Optimization | Risk factors | Clinical outcomes | Incidence | Recruitment | Peptidyl-dipeptidase A | Risk assessment | Failure analysis | Pretreatment | Heart diseases | Hypertension | Cerebral infarction | Stroke | Risk groups | Adjustment | Categories | Mortality | Regression analysis | Patients | Variance analysis | Oral cavity | Inhibitors | Converting | Angiotensin | Death | Fatalities | Infarction | Cardiovascular diseases | Health risk assessment
Journal Article